These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 25380412)
1. Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: from hit to clinic. Pizzonero M; Dupont S; Babel M; Beaumont S; Bienvenu N; Blanqué R; Cherel L; Christophe T; Crescenzi B; De Lemos E; Delerive P; Deprez P; De Vos S; Djata F; Fletcher S; Kopiejewski S; L'Ebraly C; Lefrançois JM; Lavazais S; Manioc M; Nelles L; Oste L; Polancec D; Quénéhen V; Soulas F; Triballeau N; van der Aar EM; Vandeghinste N; Wakselman E; Brys R; Saniere L J Med Chem; 2014 Dec; 57(23):10044-57. PubMed ID: 25380412 [TBL] [Abstract][Full Text] [Related]
2. Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects. Namour F; Galien R; Van Kaem T; Van der Aa A; Vanhoutte F; Beetens J; Van't Klooster G Br J Clin Pharmacol; 2016 Jul; 82(1):139-48. PubMed ID: 26852904 [TBL] [Abstract][Full Text] [Related]
3. Development and Characterization of a Fluorescent Tracer for the Free Fatty Acid Receptor 2 (FFA2/GPR43). Hansen AH; Sergeev E; Pandey SK; Hudson BD; Christiansen E; Milligan G; Ulven T J Med Chem; 2017 Jul; 60(13):5638-5645. PubMed ID: 28570808 [TBL] [Abstract][Full Text] [Related]
4. Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands. Sergeev E; Hansen AH; Pandey SK; MacKenzie AE; Hudson BD; Ulven T; Milligan G J Biol Chem; 2016 Jan; 291(1):303-17. PubMed ID: 26518871 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of 1-alkyl-5-(3,4-dichlorophenyl)- 5-[2-[(3-substituted)-1-azetidinyl]ethyl]-2-piperidones. 1. Selective antagonists of the neurokinin-2 receptor. MacKenzie AR; Marchington AP; Middleton DS; Newman SD; Jones BC J Med Chem; 2002 Nov; 45(24):5365-77. PubMed ID: 12431064 [TBL] [Abstract][Full Text] [Related]
11. Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Lee T; Schwandner R; Swaminath G; Weiszmann J; Cardozo M; Greenberg J; Jaeckel P; Ge H; Wang Y; Jiao X; Liu J; Kayser F; Tian H; Li Y Mol Pharmacol; 2008 Dec; 74(6):1599-609. PubMed ID: 18818303 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological properties of 2-nitro-3-substituted-amino benzo(b)thiophenes and their 5-chloro derivatives. Guerrera F; Salerno L; Sarvà MC; Siracusa MA; Caruso Aa L; Cutuli V Farmaco; 1992 Sep; 47(9):1149-60. PubMed ID: 1300120 [No Abstract] [Full Text] [Related]
13. Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties. Hansen AH; Sergeev E; Bolognini D; Sprenger RR; Ekberg JH; Ejsing CS; McKenzie CJ; Rexen Ulven E; Milligan G; Ulven T J Med Chem; 2018 Nov; 61(21):9534-9550. PubMed ID: 30247908 [TBL] [Abstract][Full Text] [Related]
14. Ligands at the Free Fatty Acid Receptors 2/3 (GPR43/GPR41). Milligan G; Bolognini D; Sergeev E Handb Exp Pharmacol; 2017; 236():17-32. PubMed ID: 27757758 [TBL] [Abstract][Full Text] [Related]
15. Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids. Stoddart LA; Smith NJ; Jenkins L; Brown AJ; Milligan G J Biol Chem; 2008 Nov; 283(47):32913-24. PubMed ID: 18801738 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of the free fatty acid receptor 2 (FFA2) and a novel functional FFA2-like receptor (FFA2L) for short-chain fatty acids in pigs: evidence for the existence of a duplicated FFA2 gene (FFA2L) in some mammalian species. Zhang J; Cheng S; Wang Y; Yu X; Li J Domest Anim Endocrinol; 2014 Apr; 47():108-18.e1. PubMed ID: 24315753 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-kappaB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer agents. Giri RS; Thaker HM; Giordano T; Williams J; Rogers D; Vasu KK; Sudarsanam V Bioorg Med Chem; 2010 Apr; 18(7):2796-808. PubMed ID: 20335039 [TBL] [Abstract][Full Text] [Related]